US court rules in favour of Affymetrix - Pharmaceutical Business Review

The US Court of Appeals for the Federal Circuit has ruled in favour of Affymetrix by dismissing the patent infringement lawsuits brought by Illumina regarding US Patent Nos. 7,510,841 and 7,612,020. Affymetrix executive vice president, general counsel and secretary Rick Runkel said they are pleased that the Federal Circuit has affirmed the District Court's prior rulings that Affymetrix does not infringe the asserted patents and dismissing Illumina's lawsuits.